Biomatter raises $18M Series A led by Astanor to build Vilnius enzyme lab
Tech Funding News· Abhinaya Prabhu·· 5 days agoTop DealsAI Score62
Biomatter raises $18M Series A led by Astanor to build Vilnius enzyme lab
Biomatter lands $18M from Astanor and UVC Partners to build a Vilnius enzyme lab
AI Overview
Biomatter, a Lithuanian biotech using AI to design custom enzymes, raised $18M in an oversubscribed Series A led by Astanor.
Why it matters
The round shows how proprietary lab data, not just model architecture, is becoming the moat in AI enzyme design, with named pharma and industrial customers already using the output.